Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
29/04/2008 | 12:03 | Edgar (US Regulatory) | Interpharm Holdings Inc - Amended Statement of Beneficial Ownership (SC 13D/A) | AMEX:IPA | Interpharm Holdings, Inc. |
25/04/2008 | 15:42 | Edgar (US Regulatory) | Interpharm Holdings Inc - Current report filing (8-K) | AMEX:IPA | Interpharm Holdings, Inc. |
22/04/2008 | 19:34 | Business Wire | Interpharm Announces Voluntary AMEX Delisting | AMEX:IPA | Interpharm Holdings, Inc. |
16/04/2008 | 22:15 | Business Wire | Interpharm Receives Notice from American Stock Exchange | AMEX:IPA | Interpharm Holdings, Inc. |
03/03/2008 | 22:25 | Edgar (US Regulatory) | Interpharm Holdings Inc - Statement of Changes in Beneficial Ownership (4) | AMEX:IPA | Interpharm Holdings, Inc. |
03/03/2008 | 22:24 | Edgar (US Regulatory) | Interpharm Holdings Inc - Statement of Beneficial Ownership (SC 13D) | AMEX:IPA | Interpharm Holdings, Inc. |
15/02/2008 | 23:12 | Edgar (US Regulatory) | Interpharm Holdings Inc - Quarterly Report (10-Q) | AMEX:IPA | Interpharm Holdings, Inc. |
14/02/2008 | 18:22 | Edgar (US Regulatory) | Interpharm Holdings Inc - Notification that Quarterly Report will be submitted late (NT 10-Q) | AMEX:IPA | Interpharm Holdings, Inc. |
16/01/2008 | 21:53 | Edgar (US Regulatory) | Interpharm Holdings Inc - Information Statement - All Other (definitive) (DEF 14C) | AMEX:IPA | Interpharm Holdings, Inc. |
16/01/2008 | 12:03 | Edgar (US Regulatory) | Interpharm Holdings Inc - Information Statements (revised) (PRER14C) | AMEX:IPA | Interpharm Holdings, Inc. |
26/12/2007 | 12:12 | Edgar (US Regulatory) | Interpharm Holdings Inc - Proxy Statement - Other Information (preliminary) (PRE 14C) | AMEX:IPA | Interpharm Holdings, Inc. |
19/11/2007 | 22:51 | Edgar (US Regulatory) | Interpharm Holdings Inc - Initial Statement of Beneficial Ownership (3) | AMEX:IPA | Interpharm Holdings, Inc. |
15/11/2007 | 23:25 | Edgar (US Regulatory) | Interpharm Holdings Inc - Annual Report (10-K) | AMEX:IPA | Interpharm Holdings, Inc. |
15/10/2007 | 18:06 | Edgar (US Regulatory) | Interpharm Holdings Inc - Amended Current report filing (8-K/A) | AMEX:IPA | Interpharm Holdings, Inc. |
28/09/2007 | 22:39 | Edgar (US Regulatory) | Interpharm Holdings Inc (Other) (NT 10-K) | AMEX:IPA | Interpharm Holdings, Inc. |
16/05/2007 | 15:25 | Business Wire | Interpharm Announces Financial Results for the Three Month Period Ended March 31, 2007 | AMEX:IPA | Interpharm Holdings, Inc. |
15/11/2006 | 18:15 | Business Wire | Interpharm Announces Record Revenues and Profits for the Three Month Period Ended September 30, 2006 | AMEX:IPA | Interpharm Holdings, Inc. |
03/10/2006 | 21:09 | Business Wire | Interpharm Announces Record Revenues for the Fiscal Year Ended June 30, 2006 | AMEX:IPA | Interpharm Holdings, Inc. |
02/06/2006 | 14:30 | Business Wire | Interpharm Announces Closing of $10 Million Capital Financing | AMEX:IPA | Interpharm Holdings, Inc. |
19/05/2006 | 18:50 | Business Wire | Interpharm Announces $10 Million Capital Financing | AMEX:IPA | Interpharm Holdings, Inc. |
16/05/2006 | 14:00 | Business Wire | Interpharm Continues Record Revenue for the Fiscal 2006 | AMEX:IPA | Interpharm Holdings, Inc. |
15/02/2006 | 14:00 | Business Wire | Interpharm Announces 83% Increase in Revenue for the Fiscal Quarter Ended December 31, 2005 over the Prior Year | AMEX:IPA | Interpharm Holdings, Inc. |
13/02/2006 | 23:16 | PR Newswire (US) | Wells Fargo Business Credit Provides $41.5 Million Credit Facility to Interpharm, Inc. | AMEX:IPA | Interpharm Holdings, Inc. |
22/11/2005 | 13:30 | Business Wire | Interpharm Announces Revenue and Earnings for the Fiscal Quarter Ended September 30, 2005 | AMEX:IPA | Interpharm Holdings, Inc. |
29/09/2005 | 13:30 | Business Wire | Interpharm Announces Revenue and Earnings for the Fiscal Year Ended June 30, 2005 | AMEX:IPA | Interpharm Holdings, Inc. |
21/09/2005 | 14:15 | Business Wire | Interpharm Launches Generic Equivalent of Bactrim(R) Antibiotic | AMEX:IPA | Interpharm Holdings, Inc. |
18/07/2005 | 14:04 | Business Wire | Interpharm Announces Introduction Of A Female Hormone Product With First Year Revenue Of $11.5 Million | AMEX:IPA | Interpharm Holdings, Inc. |
16/06/2004 | 15:01 | PR Newswire (US) | Watson Pharmaceuticals Announces Launch of New Acute Pain Product in Collaboration With Interpharm | AMEX:IPA | Interpharm Holdings, Inc. |
23/03/2004 | 14:19 | PR Newswire (US) | Interpharm Announces FDA Approval of Hydrocodone Bitartrate and Ibuprofen 5/200 mg Tablets, a New Dosage Strength of the Generic | AMEX:IPA | Interpharm Holdings, Inc. |
26/02/2004 | 14:25 | PR Newswire (US) | Interpharm Clarifies Comparative Financial History | NYSE:IPA | |